Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tissue Plasminogen Activator (tPA) Therapy for Acute Ischemic Stroke in Covid -19 and Non Covid -19 Patients

NCT05258565 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05258565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05258565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tissue Plasminogen Activator (tPA) Therapy for Acute Ischemic Stroke in Covid -19 and Non Covid -19 Patients
Lead sponsor
Assiut University
Phase
Phase 1
Overall status
Completed
Start date
March 1, 2022
Completion date
September 15, 2022
Enrollment
50 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke